Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.14NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FD.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CM.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.25.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.13.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBC.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GC.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.5.40NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.1.32NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.65NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BU.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EW.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.13NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BW.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FB.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.23NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.7.15NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CM.8.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.32NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.2.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FL.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
GD.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBZNNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BR.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.1.79NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.587NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.232NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.60NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CD.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CM.4.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.1.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
DE.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.333NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
CM.6.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.437NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.452NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.400NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.1.25NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JN.2.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.16 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used